Vergnolle Nathalie, Derian Claudia K, D'Andrea Michael R, Steinhoff Martin, Andrade-Gordon Patricia
Mucosal Inflammation Research Group, Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada.
J Immunol. 2002 Aug 1;169(3):1467-73. doi: 10.4049/jimmunol.169.3.1467.
It is commonly accepted that thrombin exerts its proinflammatory properties through the activation of proteinase-activated receptor (PAR)-1, although two other thrombin receptors have been discovered: PAR-3 and PAR-4. In this study, we have investigated the mechanisms and the receptors involved in thrombin-induced leukocyte/endothelial cell interactions by using selective agonists and antagonists of thrombin receptors in an in vivo intravital microscopy system. Topical addition of selective PAR-1 agonists to rat mesenteric venules failed to reproduce the increased leukocyte rolling and adhesion observed after thrombin topical addition. When added together with the selective PAR-1 antagonist RWJ-56110, thrombin was still able to provoke increased leukocyte rolling and adherence. The thrombin-induced leukocyte rolling and adherence was not affected by pretreatment of rats with an anti-platelet serum. Selective PAR-4-activating peptide was able to reproduce the effects of thrombin on leukocyte rolling and adhesion. Intraperitoneal injection of PAR-4-activating peptide also caused a significant increase in leukocyte migration into the peritoneal cavity. In rat tissues, PAR-4 expression was detected both on endothelium and isolated leukocytes. Taken together, these results showed that in rat mesenteric venules, thrombin exerts proinflammatory properties inducing leukocyte rolling and adherence, by a mechanism independent of PAR-1 activation or platelet activation. However, PAR-4 activation either on endothelial cells or on leukocytes might be responsible for the thrombin-induced effects. These findings suggest that PAR-4 activation could contribute to several early events in the inflammatory reaction, including leukocyte rolling, adherence and recruitment, and that in addition to PAR-1, PAR-4 could be involved in proinflammatory properties of thrombin.
PAR-3和PAR-4,但人们普遍认为凝血酶通过激活蛋白酶激活受体(PAR)-1发挥其促炎特性。在本研究中,我们通过在体内活体显微镜系统中使用凝血酶受体的选择性激动剂和拮抗剂,研究了凝血酶诱导白细胞/内皮细胞相互作用的机制和相关受体。向大鼠肠系膜小静脉局部添加选择性PAR-1激动剂,未能重现凝血酶局部添加后观察到的白细胞滚动和黏附增加的现象。当与选择性PAR-1拮抗剂RWJ-56110一起添加时,凝血酶仍能引发白细胞滚动和黏附增加。凝血酶诱导的白细胞滚动和黏附不受抗血小板血清预处理大鼠的影响。选择性PAR-4激活肽能够重现凝血酶对白细胞滚动和黏附的作用。腹腔注射PAR-4激活肽也导致白细胞向腹腔内迁移显著增加。在大鼠组织中,在内皮细胞和分离的白细胞上均检测到PAR-4表达。综上所述,这些结果表明,在大鼠肠系膜小静脉中,凝血酶通过一种独立于PAR-1激活或血小板激活的机制发挥促炎特性,诱导白细胞滚动和黏附。然而,内皮细胞或白细胞上的PAR-4激活可能是凝血酶诱导效应的原因。这些发现表明,PAR-4激活可能促成炎症反应中的几个早期事件,包括白细胞滚动、黏附和募集,并且除了PAR-1之外,PAR-4可能参与凝血酶的促炎特性。